Literature DB >> 10596703

Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation.

C Wojnarowski1, T Frischer, E Hofbauer, C Grabner, W Mosgoeller, I Eichler, R Ziesche.   

Abstract

In patients with cystic fibrosis (CF), the progression of pulmonary disease differs considerably, even in identical cystic fibrosis transmembrane conductance regulator-genotypes which could reflect an additional influence of the host's immune response. This study therefore measured cytokine expression patterns in CF patients with different clinical presentation. Expression of interleukin (IL)-8, interferon gamma (IFN-gamma), IL-4, IL-10, and transforming growth factor (TGF)beta(I) was assessed in bronchial mucosal biopsies of eight CF patients with acute exacerbation (age 6.0-14.2 yrs), eight CF patients with chronic stable disease (age 7.3-17.4 yrs), and in five normal control subjects by semiquantitative and quantitative reverse transcriptase polymerase chain reaction combined with histopathological assessment and immunohistochemical staining. All CF patients expressed IL-8. In acute exacerbation, expression of TGF-beta1 and IFN-gamma was either absent or extremely low. In contrast, all patients with stable disease strongly expressed TGF-beta1. The highest expression of TGF-beta1 and IFN-gamma was found in CF patients with mild disease and a history of infrequent exacerbations. No correlation was found between the expression of IL-4 and IL-10 and patient history. In normal control subjects, only a weak expression of TGF-beta1 was observed. These results show a remarkable correlation between cytokine pattern and the clinical course of cystic fibrosis. High expression of transforming growth factor-beta1 and interferon gamma was associated with mild disease, whereas no or very weak expression of these cytokines was typical for patients with acute disease and frequent exacerbations suggesting a contribution of the immune response to the progression of pulmonary disease in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596703     DOI: 10.1183/09031936.99.14511369

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Proinflammatory mediators disrupt glucose homeostasis in airway surface liquid.

Authors:  James P Garnett; Trang T Nguyen; James D Moffatt; Elizabeth R Pelham; Kameljit K Kalsi; Emma H Baker; Deborah L Baines
Journal:  J Immunol       Date:  2012-05-23       Impact factor: 5.422

Review 2.  Cystic fibrosis modifier genes.

Authors:  Jane Davies; Eric Alton; Uta Griesenbach
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

3.  Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.

Authors:  Sharmistha Bhattacharyya; Nagaraja S Balakathiresan; Clifton Dalgard; Usha Gutti; David Armistead; Cathy Jozwik; Meera Srivastava; Harvey B Pollard; Roopa Biswas
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

Review 4.  Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.

Authors:  Casimiro Gerarduzzi; John A Di Battista
Journal:  Inflamm Res       Date:  2016-12-31       Impact factor: 4.575

5.  Immunological considerations in the development of Pseudomonas aeruginosa vaccines.

Authors:  Sarah M Baker; James B McLachlan; Lisa A Morici
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

6.  Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice.

Authors:  Claudine Guilbault; Peter Stotland; Claude Lachance; Mifong Tam; Anna Keller; Luann Thompson-Snipes; Elizabeth Cowley; Thomas A Hamilton; David H Eidelman; Mary M Stevenson; Danuta Radzioch
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

Review 7.  Use of modulators of airways inflammation in patients with CF.

Authors:  Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 8.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

9.  Airway epithelial homeostasis and planar cell polarity signaling depend on multiciliated cell differentiation.

Authors:  Eszter K Vladar; Jayakar V Nayak; Carlos E Milla; Jeffrey D Axelrod
Journal:  JCI Insight       Date:  2016-08-18

10.  Regulation of airway tight junctions by proinflammatory cytokines.

Authors:  Carolyn B Coyne; Miriam K Vanhook; Todd M Gambling; Johnny L Carson; Richard C Boucher; Larry G Johnson
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.